Can ischemia-modified albumin be used to differentiate between generalized seizures and pseudoseizures?


Kamasak T., TÜREDİ S., Serin H. M. , MENTEŞE A., GÜNDÜZ A., ALVER A., ...More

TURKISH JOURNAL OF MEDICAL SCIENCES, vol.47, no.1, pp.282-286, 2017 (Peer-Reviewed Journal) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 47 Issue: 1
  • Publication Date: 2017
  • Doi Number: 10.3906/sag-1504-105
  • Journal Name: TURKISH JOURNAL OF MEDICAL SCIENCES
  • Journal Indexes: Science Citation Index Expanded, Scopus, TR DİZİN (ULAKBİM)
  • Page Numbers: pp.282-286
  • Keywords: Ischemia-modified albumin, generalized clonic tonic, albumin, IMA/albumin, MYOCARDIAL-ISCHEMIA, ICTAL HYPOXEMIA, MARKER, BIOMARKERS, BINDING

Abstract

Background/aim: In recent years ischemia-modified albumin (IMA) has been suggested as a marker that can be used in differentiating nonconvulsive conditions from epilepsy. The purpose of this study was to investigate changes in IMA levels caused by generalized clonic tonic (GTC) seizures.